Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jun 23;7(6):e016746.
doi: 10.1136/bmjopen-2017-016746.

A multicentre, randomised controlled, non-inferiority trial, comparing nasal high flow with nasal continuous positive airway pressure as primary support for newborn infants with early respiratory distress born in Australian non-tertiary special care nurseries (the HUNTER trial): study protocol

Brett J Manley  1   2 , Calum T Roberts  1   2 , Gaston R B Arnolda  3 , Ian M R Wright  4   5   6 , Louise S Owen  1   2   7 , Kim M Dalziel  8 , Jann P Foster  9   10   11 , Peter G Davis  1   2   7 , Adam G Buckmaster  6   12
Affiliations
Multicenter Study

A multicentre, randomised controlled, non-inferiority trial, comparing nasal high flow with nasal continuous positive airway pressure as primary support for newborn infants with early respiratory distress born in Australian non-tertiary special care nurseries (the HUNTER trial): study protocol

Brett J Manley et al. BMJ Open. .

Abstract

Introduction: Nasal high-flow (nHF) therapy is a popular mode of respiratory support for newborn infants. Evidence for nHF use is predominantly from neonatal intensive care units (NICUs). There are no randomised trials of nHF use in non-tertiary special care nurseries (SCNs). We hypothesise that nHF is non-inferior to nasal continuous positive airway pressure (CPAP) as primary support for newborn infants with respiratory distress, in the population cared for in non-tertiary SCNs.

Methods and analysis: The HUNTER trial is an unblinded Australian multicentre, randomised, non-inferiority trial. Infants are eligible if born at a gestational age ≥31 weeks with birth weight ≥1200 g and admitted to a participating non-tertiary SCN, are <24 hours old at randomisation and require non-invasive respiratory support or supplemental oxygen for >1 hour. Infants are randomised to treatment with either nHF or CPAP. The primary outcome is treatment failure within 72 hours of randomisation, as determined by objective oxygenation, apnoea or blood gas criteria or by a clinical decision that urgent intubation and mechanical ventilation, or transfer to a tertiary NICU, is required. Secondary outcomes include incidence of pneumothorax requiring drainage, duration of respiratory support, supplemental oxygen and hospitalisation, costs associated with hospital care, cost-effectiveness, parental stress and satisfaction and nursing workload.

Ethics and dissemination: Multisite ethical approval for the study has been granted by The Royal Children's Hospital, Melbourne, Australia (Trial Reference No. 34222), and by each participating site. The trial is currently recruiting in eight centres in Victoria and New South Wales, Australia, with one previous site no longer recruiting. The trial results will be published in a peer-reviewed journal and will be presented at national and international conferences.

Trial registration number: Australian and New Zealand Clinical Trials Registry (ANZCTR): ACTRN12614001203640; pre-results.

Keywords: neonatology; paediatrics; perinatology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Schedule of enrolment, interventions and assessments: the HUNTER trial. HF, high flow; CPAP, continuous positive airway pressure.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Blencowe H, Cousens S, Oestergaard MZ, et al. . National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162–72.10.1016/S0140-6736(12)60820-4 - DOI - PubMed
    1. Australian Institute of Health and Welfare 2016. Australia’s mothers and babies 2014—in brief. Perinatal statistics series no. 32. Cat no. PER 87. Canberra: AIHW, 2016.
    1. Buckmaster A, Arnolda G, Wright I, et al. . Targeted oxygen therapy in special care nurseries: is uniformity a good thing? J Paediatr Child Health 2012;48:476–82.10.1111/j.1440-1754.2011.02220.x - DOI - PubMed
    1. Dunn MS, Kaempf J, de Klerk A, et al. . Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011;128:e1069–e1076.10.1542/peds.2010-3848 - DOI - PubMed
    1. Morley CJ, Davis PG, Doyle LW, et al. . Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700–8.10.1056/NEJMoa072788 - DOI - PubMed

Publication types